TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT
Clinical trials for TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT explained in plain language.
Never miss a new study
Get alerted when new TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT trials appear
Sign up with your email to follow new studies for TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to help people with diabetes shed significant weight
Disease control OngoingThis large Phase 3 trial is testing whether a new injectable drug called maridebart cafraglutide helps adults with type 2 diabetes who are overweight or obese lose weight and better control their blood sugar. Over 1,100 participants will receive either the drug or a placebo for 7…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Home medical scanners aim to catch diseases before symptoms appear
Diagnosis ENROLLING_BY_INVITATIONThis study is testing whether portable ultrasound and blood glucose monitoring devices can help doctors detect chronic conditions like diabetes and heart disease earlier than standard care. 200 participants at risk for these conditions will use the devices at home for 6 months wh…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT
Phase: EARLY_PHASE1 • Sponsor: Truway Health, Inc. • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC